Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CAR-T Cell Immunotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT03696030
What this trial is testing

HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases

Who this might be right for
Malignant NeoplasmMetastatic Malignant Neoplasm in the BrainMetastatic Malignant Neoplasm in the Leptomeninges+2 more
City of Hope Medical Center 24
Early research (Phase 1)Looking for participantsNCT06623630
What this trial is testing

Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 16
Early research (Phase 1)Not Yet RecruitingNCT06946680
What this trial is testing

IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG)

Who this might be right for
High-grade GliomaDiffuse Intrinsic Pontine Glioma
University of Florida 24
Not applicableStudy completedNCT03811457
What this trial is testing

Immunotherapy With CD19 CAR T-cells in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma

Who this might be right for
Lymphoma Leukemia
UWELL Biopharma 9
Not applicableLooking for participantsNCT06717022
What this trial is testing

A Clinical Study of CHT102 in Mesothelin Positive Advanced Solid Tumors

Who this might be right for
Mesothelin Positive Tumors
Tianjin Medical University Cancer Institute and Hospital 24
Early research (Phase 1)Ended earlyNCT05262673
What this trial is testing

NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia
Shenzhen Geno-Immune Medical Institute 10
Early research (Phase 1)Looking for participantsNCT06196294
What this trial is testing

GPC3/Mesothelin-CAR-γδT Cells Against Cancers

Who this might be right for
Pancreas CancerLung CancerLiver Cancer+3 more
Second Affiliated Hospital of Guangzhou Medical University 30
Testing effectiveness (Phase 2)UnknownNCT04163302
What this trial is testing

Safety and Efficiency Study of CD19-PD1-CART Cell in Relapsed/Refractory B Cell Lymphoma

Who this might be right for
Lymphoma, B-Cell
Chinese PLA General Hospital 30
Not applicableUnknownNCT06506396
What this trial is testing

Rehabilitation Needs for Hematologic Cancer Candidate for Hematopoietic Stem Cell Transplantation or CAR T-Cell Therapy

Who this might be right for
Stem Cell TransplantationImmunotherapyCAR T-Cell Therapy
University of Modena and Reggio Emilia 20
Testing effectiveness (Phase 2)UnknownNCT02715362
What this trial is testing

GPC3 Redirected Autologous T Cells for Advanced HCC

Who this might be right for
Carcinoma, Hepatocellular
Shanghai GeneChem Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT03744676
What this trial is testing

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

Who this might be right for
Lymphoma, Non-HodgkinLymphomaLymphoma, B-Cell+7 more
Juno Therapeutics, a Subsidiary of Celgene 104
Early research (Phase 1)Active Not RecruitingNCT03330691
What this trial is testing

A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia

Who this might be right for
LeukemiaLymphoma
Seattle Children's Hospital 78
Testing effectiveness (Phase 2)Study completedNCT01865617
What this trial is testing

Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia

Who this might be right for
CD19-Positive Neoplastic Cells PresentRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Chronic Lymphocytic Leukemia+10 more
Fred Hutchinson Cancer Center 204
Early research (Phase 1)UnknownNCT04766840
What this trial is testing

Donor-derived CAR-T Cells in the Treatment of AML Patients

Who this might be right for
AML
Beijing Immunochina Medical Science & Technology Co., Ltd. 9
Large-scale testing (Phase 3)Study completedNCT03570892
What this trial is testing

Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Novartis Pharmaceuticals 330
Testing effectiveness (Phase 2)WithdrawnNCT02723942
What this trial is testing

CAR-T Cell Immunotherapy for HCC Targeting GPC3

Who this might be right for
GPC3 Positive Hepatocellular CarcinomaCAR-T Cell Immunotherapy
Fuda Cancer Hospital, Guangzhou
Early research (Phase 1)Not Yet RecruitingNCT07569263
What this trial is testing

IL-8 Receptor Modified Patient-Derived Activated CD70 CAR T Cell Therapy in Adults With Brain Metastases

Who this might be right for
Brain Metastases
University of Florida 12
Early research (Phase 1)Looking for participantsNCT04510051
What this trial is testing

CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children

Who this might be right for
Malignant Brain NeoplasmRecurrent Malignant Brain NeoplasmRefractory Malignant Brain Neoplasm
City of Hope Medical Center 18
Early research (Phase 1)Ended earlyNCT05274451
What this trial is testing

Investigate LYL797 in Adults With Solid Tumors

Who this might be right for
Triple Negative Breast CancerTNBC - Triple-Negative Breast CancerNon-small Cell Lung Cancer+20 more
Lyell Immunopharma, Inc. 57
Early research (Phase 1)UnknownNCT02915445
What this trial is testing

EpCAM CAR-T for Treatment of Advanced Solid Tumors

Who this might be right for
Malignant Neoplasm of Nasopharynx TNM Staging Distant Metastasis (M)Breast Cancer RecurrentGastric Cancer With Metastasis
Sichuan University 30
Next Page